Ivantis
Irvine
About Ivantis
Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development for the treatment of other debilitating diseases within ophthalmology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $132.4M
- Funding stage: M&A
- Last round: Series C (Jan 2017)
- Website: ivantisinc.com
- Phone: (949)600-9650
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/ivantis-32146 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.